Debt-to-equity of PharmaCyte Biotech, Inc. from 31 Jan 2012 to 31 Oct 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
PharmaCyte Biotech, Inc. quarterly Debt-to-equity in % history and change rate from 31 Jan 2012 to 31 Oct 2025.
  • PharmaCyte Biotech, Inc. Debt-to-equity for the quarter ending 31 Oct 2025 was 16%, a 66% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

PharmaCyte Biotech, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 16% -31% -66% 31 Oct 2025
Q2 2025 11% -45% -80% 31 Jul 2025
Q1 2025 19% -43% -69% 30 Apr 2025
Q4 2024 33% -2.5% -7.1% 31 Jan 2025
Q3 2024 48% +29% +153% 31 Oct 2024
Q2 2024 56% +48% +558% 31 Jul 2024
Q1 2024 62% +61% +5077% 30 Apr 2024
Q4 2023 36% +35% +2935% 31 Jan 2024
Q3 2023 19% +18% +1670% 31 Oct 2023
Q2 2023 8.6% +7.8% +1088% 31 Jul 2023
Q1 2023 1.2% +0.33% +38% 30 Apr 2023
Q4 2022 1.2% -0.07% -5.9% 31 Jan 2023
Q3 2022 1.1% -1.2% -52% 31 Oct 2022
Q2 2022 0.72% -9.8% -93% 31 Jul 2022
Q1 2022 0.87% -10% -92% 30 Apr 2022
Q4 2021 1.2% -12% -90% 31 Jan 2022
Q3 2021 2.2% -14% -87% 31 Oct 2021
Q2 2021 10% -9.8% -48% 31 Jul 2021
Q1 2021 11% -7.3% -40% 30 Apr 2021
Q4 2020 13% -3.6% -22% 31 Jan 2021
Q3 2020 16% +3.3% +25% 31 Oct 2020
Q2 2020 20% +8.3% +70% 31 Jul 2020
Q1 2020 19% +6% +48% 30 Apr 2020
Q4 2019 17% +5.1% +43% 31 Jan 2020
Q3 2019 13% -0.09% -0.71% 31 Oct 2019
Q2 2019 12% +0.08% +0.68% 31 Jul 2019
Q1 2019 13% +1.8% +17% 30 Apr 2019
Q4 2018 12% +2% +21% 31 Jan 2019
Q3 2018 13% +4.9% +59% 31 Oct 2018
Q2 2018 12% +3.6% +44% 31 Jul 2018
Q1 2018 11% +3.5% +48% 30 Apr 2018
Q4 2017 9.7% +1.8% +23% 31 Jan 2018
Q3 2017 8.3% -1.4% -14% 31 Oct 2017
Q2 2017 8.2% -3.6% -30% 31 Jul 2017
Q1 2017 7.2% -6.7% -48% 30 Apr 2017
Q4 2016 7.9% -8.5% -52% 31 Jan 2017
Q3 2016 9.7% -4.6% -32% 31 Oct 2016
Q2 2016 12% +0.01% +0.1% 31 Jul 2016
Q1 2016 14% +5% +55% 30 Apr 2016
Q4 2015 16% +12% +244% 31 Jan 2016
Q3 2015 14% +9.1% +171% 31 Oct 2015
Q2 2015 12% +3.1% +36% 31 Jul 2015
Q1 2015 9% -5.4% -38% 30 Apr 2015
Q4 2014 4.8% -63% -93% 31 Jan 2015
Q3 2014 5.3% -486% -99% 31 Oct 2014
Q2 2014 8.7% +347% 31 Jul 2014
Q1 2014 14% +209% 30 Apr 2014
Q4 2013 68% +246% 31 Jan 2014
Q3 2013 491% +660% 31 Oct 2013
Q2 2013 -339% -178% -111% 31 Jul 2013
Q1 2013 -195% -42% -27% 30 Apr 2013
Q4 2012 -177% -36% -25% 31 Jan 2013
Q3 2012 -169% 31 Oct 2012
Q2 2012 -160% 31 Jul 2012
Q1 2012 -153% 30 Apr 2012
Q4 2011 -142% 31 Jan 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.